The briefing
A novel urine-based assay outperformed multiparametric MRI in detecting progression among men on active surveillance for prostate cancer, Pharmacy Times reports. The approach could reduce unnecessary biopsies and improve monitoring accuracy.
Original headline
Urine Test May Improve Active Surveillance Monitoring in Prostate Cancer